{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,5,14]],"date-time":"2026-05-14T16:12:26Z","timestamp":1778775146813,"version":"3.51.4"},"reference-count":38,"publisher":"Elsevier BV","issue":"11","license":[{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,11,1]],"date-time":"2025-11-01T00:00:00Z","timestamp":1761955200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473997"],"award-info":[{"award-number":["82473997"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["jpharmsci.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Pharmaceutical Sciences"],"published-print":{"date-parts":[[2025,11]]},"DOI":"10.1016\/j.xphs.2025.103994","type":"journal-article","created":{"date-parts":[[2025,9,17]],"date-time":"2025-09-17T05:33:55Z","timestamp":1758087235000},"page":"103994","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"title":["PK\/PD modeling of the effect of Escitalopram combined with Docetaxel in the treatment of breast cancer with depression in mice"],"prefix":"10.1016","volume":"114","author":[{"given":"Tian-yu","family":"Wang","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jun-sheng","family":"Xue","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lei","family":"Cai","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Chen","family":"Liu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Tian-yu","family":"Bao","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xin-yu","family":"Hou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2583-8080","authenticated-orcid":false,"given":"Tian-yan","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.xphs.2025.103994_bib0001","doi-asserted-by":"crossref","DOI":"10.3389\/fpsyg.2021.585534","article-title":"Depression and anxiety in patients with cancer: a cross-sectional study","volume":"12","author":"Naser","year":"2021","journal-title":"Front Psychol"},{"issue":"8","key":"10.1016\/j.xphs.2025.103994_bib0002","doi-asserted-by":"crossref","first-page":"2531","DOI":"10.1002\/cam4.3794","article-title":"Symptom clusters experienced by breast cancer patients at various treatment stages: a systematic review","volume":"10","author":"So","year":"2021","journal-title":"Cancer Med"},{"issue":"12","key":"10.1016\/j.xphs.2025.103994_bib0003","doi-asserted-by":"crossref","first-page":"3186","DOI":"10.1038\/s41380-020-00865-6","article-title":"Prognostic value of depression and anxiety on breast cancer recurrence and mortality: a systematic review and meta-analysis of 282,203 patients","volume":"25","author":"Wang","year":"2020","journal-title":"Mol Psychiatry"},{"issue":"2\u20133","key":"10.1016\/j.xphs.2025.103994_bib0004","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1016\/j.jad.2012.03.025","article-title":"Anxiety and depression after cancer diagnosis: prevalence rates by cancer type, gender, and age","volume":"141","author":"Linden","year":"2012","journal-title":"J Affect Disord"},{"issue":"2","key":"10.1016\/j.xphs.2025.103994_bib0005","doi-asserted-by":"crossref","DOI":"10.1002\/jcla.22263","article-title":"Plasma serotonin level is a predictor for recurrence and poor prognosis in colorectal cancer patients","volume":"32","author":"Xia","year":"2018","journal-title":"J Clin Lab Anal"},{"key":"10.1016\/j.xphs.2025.103994_bib0006","article-title":"Serotonin transporter inhibits antitumor immunity through regulating the intratumoral serotonin axis","author":"Li","year":"2025","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.xphs.2025.103994_bib0007","article-title":"Antidepressants for the treatment of depression in people with cancer","volume":"3","author":"Vita","year":"2023","journal-title":"Cochrane Database Syst Rev"},{"issue":"5","key":"10.1016\/j.xphs.2025.103994_bib0008","doi-asserted-by":"crossref","first-page":"897","DOI":"10.1017\/S0033291713001372","article-title":"Treatment of depression in adults with cancer: a systematic review of randomized controlled trials","volume":"44","author":"Walker","year":"2014","journal-title":"Psychol Med"},{"issue":"5","key":"10.1016\/j.xphs.2025.103994_bib0009","doi-asserted-by":"crossref","first-page":"573","DOI":"10.1002\/pon.4286","article-title":"Systematic review and meta-analysis of collaborative care interventions for depression in patients with cancer","volume":"26","author":"Li","year":"2017","journal-title":"Psychooncology"},{"issue":"1","key":"10.1016\/j.xphs.2025.103994_bib0010","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1038\/npp.2015.171","article-title":"Stress effects on neuronal structure: hippocampus, amygdala, and prefrontal cortex","volume":"41","author":"McEwen","year":"2016","journal-title":"Neuropsychopharmacology,"},{"issue":"4","key":"10.1016\/j.xphs.2025.103994_bib0011","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1002\/da.22084","article-title":"Cytokine targets in the brain: impact on neurotransmitters and neurocircuits","volume":"30","author":"Miller","year":"2013","journal-title":"Depress Anxiety"},{"issue":"3","key":"10.1016\/j.xphs.2025.103994_bib0012","doi-asserted-by":"crossref","first-page":"230","DOI":"10.1016\/j.jad.2011.08.003","article-title":"Interleukin (IL)-6, tumour necrosis factor alpha (TNF-alpha) and soluble interleukin-2 receptors (sIL-2R) are elevated in patients with major depressive disorder: a meta-analysis and meta-regression","volume":"139","author":"Liu","year":"2012","journal-title":"J Affect Disord"},{"issue":"3","key":"10.1016\/j.xphs.2025.103994_bib0013","doi-asserted-by":"crossref","first-page":"736","DOI":"10.1016\/j.jad.2013.06.004","article-title":"CRP, IL-6 and depression: a systematic review and meta-analysis of longitudinal studies","volume":"150","author":"Valkanova","year":"2013","journal-title":"J Affect Disord"},{"key":"10.1016\/j.xphs.2025.103994_bib0014","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.bbi.2015.04.010","article-title":"Pre-treatment effects of peripheral tumors on brain and behavior: neuroinflammatory mechanisms in humans and rodents","volume":"49","author":"Schrepf","year":"2015","journal-title":"Brain Behav Immun"},{"key":"10.1016\/j.xphs.2025.103994_bib0015","doi-asserted-by":"crossref","first-page":"88","DOI":"10.1016\/j.jneuroim.2015.08.012","article-title":"Neurocognitive function, brain-derived neurotrophic factor (BDNF) and IL-6 levels in cancer patients with depression","volume":"287","author":"Jehn","year":"2015","journal-title":"J Neuroimmunol"},{"key":"10.1016\/j.xphs.2025.103994_bib0016","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.bbi.2023.12.014","article-title":"The biology of hope: inflammatory and neuroendocrine profiles in ovarian cancer patients","volume":"116","author":"Lutgendorf","year":"2024","journal-title":"Brain Behav Immun"},{"issue":"3","key":"10.1016\/j.xphs.2025.103994_bib0017","first-page":"2539","article-title":"Efficacy analysis of trastuzumab, carboplatin and docetaxel in HER-2-positive breast cancer patients","volume":"19","author":"Wu","year":"2020","journal-title":"Oncol Lett"},{"issue":"2","key":"10.1016\/j.xphs.2025.103994_bib0018","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1007\/s00280-021-04374-3","article-title":"Association between gene polymorphism and adverse effects in cancer patients receiving docetaxel treatment: a meta-analysis","volume":"89","author":"Yan","year":"2022","journal-title":"Cancer Chemother Pharmacol"},{"issue":"1","key":"10.1016\/j.xphs.2025.103994_bib0019","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1093\/bja\/aet208","article-title":"Neuropathic pain in cancer","volume":"111","author":"Fallon","year":"2013","journal-title":"Br J Anaesth"},{"issue":"9","key":"10.1016\/j.xphs.2025.103994_bib0020","doi-asserted-by":"crossref","first-page":"935","DOI":"10.1097\/CAD.0000000000001383","article-title":"Sertraline inhibits stress-induced tumor growth through regulating CD8 + T cell-mediated anti-tumor immunity","volume":"33","author":"Zhou","year":"2022","journal-title":"Anticancer Drugs"},{"issue":"10","key":"10.1016\/j.xphs.2025.103994_bib0021","first-page":"12","article-title":"Antidepressant drug sertraline against Human cancer cells","author":"Duarte","year":"2022","journal-title":"Biomolecules"},{"issue":"2","key":"10.1016\/j.xphs.2025.103994_bib0022","doi-asserted-by":"crossref","first-page":"214","DOI":"10.1002\/wps.20765","article-title":"Safety of 80 antidepressants, antipsychotics, anti-attention-deficit\/hyperactivity medications and mood stabilizers in children and adolescents with psychiatric disorders: a large scale systematic meta-review of 78 adverse effects","volume":"19","author":"Solmi","year":"2020","journal-title":"World Psychiatry"},{"issue":"4","key":"10.1016\/j.xphs.2025.103994_bib0023","doi-asserted-by":"crossref","first-page":"186","DOI":"10.1016\/j.tips.2008.01.007","article-title":"Mechanism-based pharmacokinetic-pharmacodynamic (PK-PD) modeling in translational drug research","volume":"29","author":"Danhof","year":"2008","journal-title":"Trends Pharmacol Sci"},{"key":"10.1016\/j.xphs.2025.103994_bib0024","doi-asserted-by":"crossref","DOI":"10.1016\/j.neulet.2021.135851","article-title":"Depression promotes lung carcinoma progression by regulating the tumor microenvironment in tumor-bearing models of C57BL\/6J mice","volume":"754","author":"Cui","year":"2021","journal-title":"Neurosci Lett"},{"key":"10.1016\/j.xphs.2025.103994_bib0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2022.156115","article-title":"Disruption of IDO signaling pathway alleviates chronic unpredictable mild stress-induced depression-like behaviors and tumor progression in mice with breast cancer","volume":"162","author":"Chen","year":"2023","journal-title":"Cytokine"},{"key":"10.1016\/j.xphs.2025.103994_bib0026","doi-asserted-by":"crossref","DOI":"10.1016\/j.brainres.2024.149123","article-title":"The chronic unpredictable mild stress (CUMS) paradigm: bridging the gap in depression research from bench to bedside","volume":"1843","author":"Sharma","year":"2024","journal-title":"Brain Res"},{"issue":"1","key":"10.1016\/j.xphs.2025.103994_bib0027","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1208\/s12248-008-9007-x","article-title":"A flexible nonlinear feedback system that captures diverse patterns of adaptation and rebound","volume":"10","author":"Gabrielsson","year":"2008","journal-title":"AAPS J"},{"issue":"2","key":"10.1016\/j.xphs.2025.103994_bib0028","doi-asserted-by":"crossref","first-page":"179","DOI":"10.1007\/s10928-009-9117-9","article-title":"Modeling of tumor growth and anticancer effects of combination therapy","volume":"36","author":"Koch","year":"2009","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"1","key":"10.1016\/j.xphs.2025.103994_bib0029","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1007\/s10928-020-09673-5","article-title":"Disease progression model of 4T1 metastatic breast cancer","volume":"47","author":"Yang","year":"2020","journal-title":"J Pharmacokinet Pharmacodyn"},{"issue":"4","key":"10.1016\/j.xphs.2025.103994_bib0030","doi-asserted-by":"crossref","first-page":"281","DOI":"10.2165\/00003088-200746040-00002","article-title":"The clinical pharmacokinetics of escitalopram","volume":"46","author":"Rao","year":"2007","journal-title":"Clin Pharmacokinet"},{"issue":"2","key":"10.1016\/j.xphs.2025.103994_bib0031","doi-asserted-by":"crossref","first-page":"276","DOI":"10.1038\/bjp.2008.243","article-title":"Prediction of clinical response based on pharmacokinetic\/pharmacodynamic models of 5-hydroxytryptamine reuptake inhibitors in mice","volume":"155","author":"Kreilgaard","year":"2008","journal-title":"Br J Pharmacol"},{"issue":"1","key":"10.1016\/j.xphs.2025.103994_bib0032","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1124\/jpet.117.243931","article-title":"Pharmacokinetic\/pharmacodynamic modeling of schedule-dependent interaction between Docetaxel and Cabozantinib in Human prostate cancer xenograft models","volume":"364","author":"Chen","year":"2018","journal-title":"J Pharmacol Exp Ther"},{"issue":"3","key":"10.1016\/j.xphs.2025.103994_bib0033","doi-asserted-by":"crossref","first-page":"1094","DOI":"10.1158\/0008-5472.CAN-03-2524","article-title":"Predictive pharmacokinetic-pharmacodynamic modeling of tumor growth kinetics in xenograft models after administration of anticancer agents","volume":"64","author":"Simeoni","year":"2004","journal-title":"Cancer Res"},{"key":"10.1016\/j.xphs.2025.103994_bib0034","doi-asserted-by":"crossref","first-page":"494","DOI":"10.1016\/j.bbr.2017.05.064","article-title":"Behavioral, inflammatory and neurochemical disturbances in LPS and UCMS-induced mouse models of depression","volume":"364","author":"Zhao","year":"2019","journal-title":"Behav Brain Res"},{"issue":"1","key":"10.1016\/j.xphs.2025.103994_bib0035","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1186\/s12974-022-02508-9","article-title":"A tale of two transmitters: serotonin and histamine as in vivo biomarkers of chronic stress in mice","volume":"19","author":"Hersey","year":"2022","journal-title":"J Neuroinflammation"},{"issue":"4","key":"10.1016\/j.xphs.2025.103994_bib0036","first-page":"252","article-title":"Additive effects of ulinastatin and docetaxel on growth of breast cancer xenograft in nude mice and expression of PGE2, IL-10, and IL-2 in primary breast cancer cells","volume":"27","author":"Zhong","year":"2012","journal-title":"Cancer Biother Radiopharm"},{"issue":"1","key":"10.1016\/j.xphs.2025.103994_bib0037","doi-asserted-by":"crossref","first-page":"43","DOI":"10.1186\/s12951-020-00604-7","article-title":"Docetaxel-loaded solid lipid nanoparticles prevent tumor growth and lung metastasis of 4T1 murine mammary carcinoma cells","volume":"18","author":"da Rocha","year":"2020","journal-title":"J Nanobiotechnology"},{"issue":"8","key":"10.1016\/j.xphs.2025.103994_bib0038","doi-asserted-by":"crossref","first-page":"1340","DOI":"10.1038\/bjc.2015.74","article-title":"Cytokine profiling of docetaxel-resistant castration-resistant prostate cancer","volume":"112","author":"Mahon","year":"2015","journal-title":"Br J Cancer"}],"container-title":["Journal of Pharmaceutical Sciences"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925004484?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022354925004484?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,10]],"date-time":"2026-03-10T03:09:56Z","timestamp":1773112196000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0022354925004484"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,11]]},"references-count":38,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2025,11]]}},"alternative-id":["S0022354925004484"],"URL":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103994","relation":{},"ISSN":["0022-3549"],"issn-type":[{"value":"0022-3549","type":"print"}],"subject":[],"published":{"date-parts":[[2025,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"PK\/PD modeling of the effect of Escitalopram combined with Docetaxel in the treatment of breast cancer with depression in mice","name":"articletitle","label":"Article Title"},{"value":"Journal of Pharmaceutical Sciences","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.xphs.2025.103994","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 American Pharmacists Association. Published by Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"103994"}}